Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne (TECH) trades at $72.37, down slightly by 0.06% on the day. The stock exhibits a bullish technical trend with moving averages supporting upside momentum, while oscillators remain neutral. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026. The company maintains strong profitability margins, including a gross profit margin of 65.77% and net income margin of 14.97%. Key developments include a pending acquisition by Merck KGaA at $73.00 per share and ongoing shareholder investigations regarding the deal's fairness.
The outlook for TECH is cautiously optimistic, driven by the acquisition premium and solid fundamentals, but risks include integration challenges and shareholder litigation. Analyst consensus is divided with 46% buy ratings and a price target of $65.78, slightly below the current price. Investors should weigh the acquisition's completion against execution risks and market sentiment.
Read full analysis

Key Stats

  • Market Cap
    $11.35B
  • Volume
    5,019,526
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $11.37B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.47
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Class action lawsuit filed against Capricor Therapeutics over misleading FDA approval claims.

Capricor Therapeutics faces a class action lawsuit alleging it made false statements about the progress of its drug deramiocel towards FDA approval. The lawsuit claims the company misled investors by promoting positive trial results while knowing of ...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Class action lawsuit filed against Capricor Therapeutics over misleading FDA approval claims.

Alibaba unveils AI chip and plans 20GW data center capacity by 2032 to boost AI infrastructure.

Alibaba announced its new AI chip, the Zhenwu V900, which offers three times the performance of its predecessor, and plans to expand its global data center capacity to over 20 gigawatts by 2032. This move aims to strengthen Alibaba Cloud's position i...

Market News
4 hours ago
CNBC
Bullish
news icon
Alibaba unveils AI chip and plans 20GW data center capacity by 2032 to boost AI infrastructure.

Index volatility drops after Fed rate hike, but single stock volatility rises.

Last week, overall market volatility decreased following the Federal Reserve's expected 25 basis point rate increase. While index volatility, measured by the VIX Index, declined, volatility for individual stocks actually rose, as seen in the divergen...

Market News
5 hours ago
Seeking Alpha
Neutral
Index volatility drops after Fed rate hike, but single stock volatility rises.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.35B
  • Volume
    5,019,526
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $11.37B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.47
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!